Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Sharp

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Circulation Research|December 28, 2022
Hydrogen Sulfide Modulates Endothelial-Mesenchymal Transition in Heart FailureZhen Li, Huijing Xia, Thomas E Sharp, et al.
JACC. Basic to Translational Science|August 1, 2018
Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection FractionThomas E Sharp, Hajime Kubo, Remus M Berretta, et al.
Iscience|January 19, 2026
MCD enzyme deficiency drives early mortality and multiorgan metabolic disruption in Dahl salt-sensitive ratsOlha Kravtsova, Yifan Tan, Vladislav Levchenko, et al.
Journal of the American Heart Association|February 14, 2024
Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection FractionJake E Doiron, Zhen Li, Xiaoman Yu, et al.
British Journal of Pharmacology|July 10, 2024
Adjunctive therapy with an oral H<sub>2</sub>S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fractionJake E Doiron, Huijing Xia, Xiaoman Yu, et al.
Journal of the American Heart Association|February 8, 2023
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine ModelKyle B LaPenna, Zhen Li, Jake E Doiron, et al.
Scientific Reports|November 30, 2017
A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary FunctionMarkus Wallner, Deborah M Eaton, Remus M Berretta, et al.
Circulation Research|June 15, 2022
Mitochondrial H<sub>2</sub>S Regulates BCAA Catabolism in Heart FailureZhen Li, Huijing Xia, Thomas E Sharp, et al.
Circulation Research|April 11, 2014
Sorafenib cardiotoxicity increases mortality after myocardial infarctionJason M Duran, Catherine A Makarewich, Danielle Trappanese, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Integrated systems biology identifies disruptions in mitochondrial function and metabolism as key contributors to heart failure with preserved ejection fraction (HFpEF)Andrew A Gibb, Kyle LaPenna, Ryan B Gaspar, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Circulation Research|December 28, 2022
Hydrogen Sulfide Modulates Endothelial-Mesenchymal Transition in Heart FailureZhen Li, Huijing Xia, Thomas E Sharp, et al.
JACC. Basic to Translational Science|August 1, 2018
Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection FractionThomas E Sharp, Hajime Kubo, Remus M Berretta, et al.
Iscience|January 19, 2026
MCD enzyme deficiency drives early mortality and multiorgan metabolic disruption in Dahl salt-sensitive ratsOlha Kravtsova, Yifan Tan, Vladislav Levchenko, et al.
Journal of the American Heart Association|February 14, 2024
Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection FractionJake E Doiron, Zhen Li, Xiaoman Yu, et al.
British Journal of Pharmacology|July 10, 2024
Adjunctive therapy with an oral H<sub>2</sub>S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fractionJake E Doiron, Huijing Xia, Xiaoman Yu, et al.
Journal of the American Heart Association|February 8, 2023
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine ModelKyle B LaPenna, Zhen Li, Jake E Doiron, et al.
Scientific Reports|November 30, 2017
A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary FunctionMarkus Wallner, Deborah M Eaton, Remus M Berretta, et al.
Circulation Research|June 15, 2022
Mitochondrial H<sub>2</sub>S Regulates BCAA Catabolism in Heart FailureZhen Li, Huijing Xia, Thomas E Sharp, et al.
Circulation Research|April 11, 2014
Sorafenib cardiotoxicity increases mortality after myocardial infarctionJason M Duran, Catherine A Makarewich, Danielle Trappanese, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Integrated systems biology identifies disruptions in mitochondrial function and metabolism as key contributors to heart failure with preserved ejection fraction (HFpEF)Andrew A Gibb, Kyle LaPenna, Ryan B Gaspar, et al.
Pageof 5